APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ertapenem Sodium for Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ertapenem Sodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173989340326 December 2025199 pages

Choose your research edition.

Industry ResearchErtapenem Sodium for Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ertapenem Sodium for Injection Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Ertapenem Sodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ertapenem Sodium for Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ertapenem Sodium for Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ertapenem Sodium for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ertapenem Sodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ertapenem Sodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ertapenem Sodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ertapenem Sodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ertapenem Sodium for Injection include Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Unitech Biotech, Par Pharmaceutical, NorthStar Rx and Intelicure Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ertapenem Sodium for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ertapenem Sodium for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ertapenem Sodium for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ertapenem Sodium for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Ertapenem Sodium for Injection Segment by Company

Chongqing Shenghuaxi Pharmaceutical Co., Ltd.

Sichuan Pharmaceutical Preparation Co., Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Qilu Anti Pharmaceutical Co., Ltd.

Hainan Herui Pharmaceutical Co., Ltd.

Unitech Biotech

Par Pharmaceutical

NorthStar Rx

Intelicure Lifesciences

EUGIA PHARMA INC

ACS DOBFAR SPA

Ertapenem Sodium for Injection Segment by Type

0.5g

1g

Ertapenem Sodium for Injection Segment by Application

Hospital

Clinic

Other

Ertapenem Sodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ertapenem Sodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ertapenem Sodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ertapenem Sodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ertapenem Sodium for Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ertapenem Sodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ertapenem Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ertapenem Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ertapenem Sodium for Injection Industry Trends Table 2. Ertapenem Sodium for Injection Industry Drivers Table 3. Ertapenem Sodium for Injection Industry Opportunities and Challenges Table 4. Ertapenem Sodium for Injection Industry Restraints Table 5. Global Ertapenem Sodium for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ertapenem Sodium for Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ertapenem Sodium for Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Ertapenem Sodium for Injection Sales Market Share by Manufacturers Table 9. Global Ertapenem Sodium for Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Ertapenem Sodium for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ertapenem Sodium for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ertapenem Sodium for Injection Manufacturers, Product Type & Application Table 13. Global Ertapenem Sodium for Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ertapenem Sodium for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.5g Table 17. Major Manufacturers of 1g Table 18. Global Ertapenem Sodium for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Ertapenem Sodium for Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2026) Table 22. Global Ertapenem Sodium for Injection Sales Market Share by Type (2027-2032) Table 23. Global Ertapenem Sodium for Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Ertapenem Sodium for Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Ertapenem Sodium for Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2026) Table 27. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Ertapenem Sodium for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Ertapenem Sodium for Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Ertapenem Sodium for Injection Sales Market Share by Application (2021-2026) Table 35. Global Ertapenem Sodium for Injection Sales Market Share by Application (2027-2032) Table 36. Global Ertapenem Sodium for Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Ertapenem Sodium for Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Ertapenem Sodium for Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2026) Table 40. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2027-2032) Table 41. Global Ertapenem Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Ertapenem Sodium for Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Ertapenem Sodium for Injection Sales Market Share by Region (2021-2026) Table 44. Global Ertapenem Sodium for Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Ertapenem Sodium for Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Ertapenem Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Ertapenem Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Ertapenem Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Ertapenem Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Ertapenem Sodium for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Ertapenem Sodium for Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Ertapenem Sodium for Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Ertapenem Sodium for Injection Revenue Market Share by Region (2021-2026) Table 62. Global Ertapenem Sodium for Injection Revenue Market Share by Region (2027-2032) Table 63. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information Table 64. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview Table 65. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 67. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Development Table 68. Sichuan Pharmaceutical Preparation Co., Ltd. Company Information Table 69. Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview Table 70. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 72. Sichuan Pharmaceutical Preparation Co., Ltd. Recent Development Table 73. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information Table 74. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview Table 75. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 77. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Development Table 78. Qilu Anti Pharmaceutical Co., Ltd. Company Information Table 79. Qilu Anti Pharmaceutical Co., Ltd. Business Overview Table 80. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 82. Qilu Anti Pharmaceutical Co., Ltd. Recent Development Table 83. Hainan Herui Pharmaceutical Co., Ltd. Company Information Table 84. Hainan Herui Pharmaceutical Co., Ltd. Business Overview Table 85. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 87. Hainan Herui Pharmaceutical Co., Ltd. Recent Development Table 88. Unitech Biotech Company Information Table 89. Unitech Biotech Business Overview Table 90. Unitech Biotech Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Unitech Biotech Ertapenem Sodium for Injection Product Portfolio Table 92. Unitech Biotech Recent Development Table 93. Par Pharmaceutical Company Information Table 94. Par Pharmaceutical Business Overview Table 95. Par Pharmaceutical Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio Table 97. Par Pharmaceutical Recent Development Table 98. NorthStar Rx Company Information Table 99. NorthStar Rx Business Overview Table 100. NorthStar Rx Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. NorthStar Rx Ertapenem Sodium for Injection Product Portfolio Table 102. NorthStar Rx Recent Development Table 103. Intelicure Lifesciences Company Information Table 104. Intelicure Lifesciences Business Overview Table 105. Intelicure Lifesciences Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio Table 107. Intelicure Lifesciences Recent Development Table 108. EUGIA PHARMA INC Company Information Table 109. EUGIA PHARMA INC Business Overview Table 110. EUGIA PHARMA INC Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio Table 112. EUGIA PHARMA INC Recent Development Table 113. ACS DOBFAR SPA Company Information Table 114. ACS DOBFAR SPA Business Overview Table 115. ACS DOBFAR SPA Ertapenem Sodium for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio Table 117. ACS DOBFAR SPA Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Ertapenem Sodium for Injection Distributors List Table 121. Ertapenem Sodium for Injection Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Ertapenem Sodium for Injection Product Image Figure 2. Global Ertapenem Sodium for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ertapenem Sodium for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ertapenem Sodium for Injection Sales (2021-2032) & (K Units) Figure 5. Global Ertapenem Sodium for Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ertapenem Sodium for Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.5g Image Figure 9. 1g Image Figure 10. Global Ertapenem Sodium for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Ertapenem Sodium for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2032) Figure 13. Global Ertapenem Sodium for Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Ertapenem Sodium for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Ertapenem Sodium for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Ertapenem Sodium for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Ertapenem Sodium for Injection Sales Market Share by Application (2021-2032) Figure 22. Global Ertapenem Sodium for Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Ertapenem Sodium for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Ertapenem Sodium for Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Ertapenem Sodium for Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Ertapenem Sodium for Injection Sales Market Share by Country (2021-2032) Figure 39. China Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Ertapenem Sodium for Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Ertapenem Sodium for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Ertapenem Sodium for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Ertapenem Sodium for Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Ertapenem Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Ertapenem Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Ertapenem Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Ertapenem Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Ertapenem Sodium for Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Ertapenem Sodium for Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5g
  • 1g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  • Sichuan Pharmaceutical Preparation Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  • Qilu Anti Pharmaceutical Co., Ltd.
  • Hainan Herui Pharmaceutical Co., Ltd.
  • Unitech Biotech
  • Par Pharmaceutical
  • NorthStar Rx
  • Intelicure Lifesciences
  • EUGIA PHARMA INC
  • ACS DOBFAR SPA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ertapenem Sodium for Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ertapenem Sodium for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ertapenem Sodium for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ertapenem Sodium for Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ertapenem Sodium for Injection Market Dynamics
  1. 2.1 Ertapenem Sodium for Injection Industry Trends
  2. 2.2 Ertapenem Sodium for Injection Industry Drivers
  3. 2.3 Ertapenem Sodium for Injection Industry Opportunities and Challenges
  4. 2.4 Ertapenem Sodium for Injection Industry Restraints
3 Ertapenem Sodium for Injection Market by Manufacturers
  1. 3.1 Global Ertapenem Sodium for Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ertapenem Sodium for Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ertapenem Sodium for Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ertapenem Sodium for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ertapenem Sodium for Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ertapenem Sodium for Injection Manufacturers, Product Type & Application
  7. 3.7 Global Ertapenem Sodium for Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ertapenem Sodium for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ertapenem Sodium for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ertapenem Sodium for Injection Tier 1, Tier 2, and Tier 3
4 Ertapenem Sodium for Injection Market by Type
  1. 4.1 Ertapenem Sodium for Injection Type Introduction
  2. 4.1.1 0.5g
  3. 4.1.2 1g
  4. 4.2 Global Ertapenem Sodium for Injection Sales by Type
  5. 4.2.1 Global Ertapenem Sodium for Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ertapenem Sodium for Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Ertapenem Sodium for Injection Revenue by Type
  9. 4.3.1 Global Ertapenem Sodium for Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ertapenem Sodium for Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2032)
5 Ertapenem Sodium for Injection Market by Application
  1. 5.1 Ertapenem Sodium for Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Ertapenem Sodium for Injection Sales by Application
  6. 5.2.1 Global Ertapenem Sodium for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ertapenem Sodium for Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Ertapenem Sodium for Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Ertapenem Sodium for Injection Revenue by Application
  10. 5.3.1 Global Ertapenem Sodium for Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ertapenem Sodium for Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2032)
6 Global Ertapenem Sodium for Injection Sales by Region
  1. 6.1 Global Ertapenem Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ertapenem Sodium for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Ertapenem Sodium for Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Ertapenem Sodium for Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ertapenem Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ertapenem Sodium for Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ertapenem Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ertapenem Sodium for Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ertapenem Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ertapenem Sodium for Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ertapenem Sodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ertapenem Sodium for Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ertapenem Sodium for Injection Revenue by Region
  1. 7.1 Global Ertapenem Sodium for Injection Revenue by Region
  2. 7.1.1 Global Ertapenem Sodium for Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ertapenem Sodium for Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Ertapenem Sodium for Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Ertapenem Sodium for Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ertapenem Sodium for Injection Revenue (2021-2032)
  8. 7.2.2 North America Ertapenem Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ertapenem Sodium for Injection Revenue (2021-2032)
  11. 7.3.2 Europe Ertapenem Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ertapenem Sodium for Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ertapenem Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ertapenem Sodium for Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ertapenem Sodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  2. 8.1.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  6. 8.1.5 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Sichuan Pharmaceutical Preparation Co., Ltd.
  8. 8.2.1 Sichuan Pharmaceutical Preparation Co., Ltd. Company Information
  9. 8.2.2 Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview
  10. 8.2.3 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  12. 8.2.5 Sichuan Pharmaceutical Preparation Co., Ltd. Recent Developments
  13. 8.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  14. 8.3.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  18. 8.3.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Qilu Anti Pharmaceutical Co., Ltd.
  20. 8.4.1 Qilu Anti Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Qilu Anti Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  24. 8.4.5 Qilu Anti Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Hainan Herui Pharmaceutical Co., Ltd.
  26. 8.5.1 Hainan Herui Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Hainan Herui Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  30. 8.5.5 Hainan Herui Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Unitech Biotech
  32. 8.6.1 Unitech Biotech Company Information
  33. 8.6.2 Unitech Biotech Business Overview
  34. 8.6.3 Unitech Biotech Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Unitech Biotech Ertapenem Sodium for Injection Product Portfolio
  36. 8.6.5 Unitech Biotech Recent Developments
  37. 8.7 Par Pharmaceutical
  38. 8.7.1 Par Pharmaceutical Company Information
  39. 8.7.2 Par Pharmaceutical Business Overview
  40. 8.7.3 Par Pharmaceutical Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio
  42. 8.7.5 Par Pharmaceutical Recent Developments
  43. 8.8 NorthStar Rx
  44. 8.8.1 NorthStar Rx Company Information
  45. 8.8.2 NorthStar Rx Business Overview
  46. 8.8.3 NorthStar Rx Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NorthStar Rx Ertapenem Sodium for Injection Product Portfolio
  48. 8.8.5 NorthStar Rx Recent Developments
  49. 8.9 Intelicure Lifesciences
  50. 8.9.1 Intelicure Lifesciences Company Information
  51. 8.9.2 Intelicure Lifesciences Business Overview
  52. 8.9.3 Intelicure Lifesciences Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio
  54. 8.9.5 Intelicure Lifesciences Recent Developments
  55. 8.10 EUGIA PHARMA INC
  56. 8.10.1 EUGIA PHARMA INC Company Information
  57. 8.10.2 EUGIA PHARMA INC Business Overview
  58. 8.10.3 EUGIA PHARMA INC Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio
  60. 8.10.5 EUGIA PHARMA INC Recent Developments
  61. 8.11 ACS DOBFAR SPA
  62. 8.11.1 ACS DOBFAR SPA Company Information
  63. 8.11.2 ACS DOBFAR SPA Business Overview
  64. 8.11.3 ACS DOBFAR SPA Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio
  66. 8.11.5 ACS DOBFAR SPA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ertapenem Sodium for Injection Value Chain Analysis
  2. 9.1.1 Ertapenem Sodium for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ertapenem Sodium for Injection Production Mode & Process
  6. 9.2 Ertapenem Sodium for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ertapenem Sodium for Injection Distributors
  9. 9.2.3 Ertapenem Sodium for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst